tiprankstipranks
GlaxoSmithKline (GSK)
NYSE:GSK
US Market
Holding GSK?
Track your performance easily

GlaxoSmithKline (GSK) Technical Analysis

4,881 Followers

Technical Sentiment

Overall Consensus
Neutral
11Bullish
2Neutral
9Bearish
Technical Analysis Consensus
Sell
3Bullish
2Neutral
5Bearish
Moving Average Consensus
Buy
8Bullish
0Neutral
4Bearish
GlaxoSmithKline’s (GSK) Moving Averages Convergence Divergence (MACD) indicator is 0.11, suggesting GlaxoSmithKline is a Sell.
GlaxoSmithKline’s (GSK) 20-Day exponential moving average is 33.96, while GlaxoSmithKline’s (GSK) share price is $35.1, making it a Buy.
GlaxoSmithKline’s (GSK) 50-Day exponential moving average is 34.51, while GlaxoSmithKline’s (GSK) share price is $35.1, making it a Buy.

GlaxoSmithKline (GSK) Pivot Points

Jan 30, 2025, 05:57 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
34.38
34.61
35.05
35.28
35.72
35.95
36.39
Fibonacci
34.61
34.86
35.02
35.28
35.53
35.69
35.95
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

GlaxoSmithKline (GSK) Moving Averages

Jan 30, 2025, 05:57 AM
Period
Simple
Exponential
MA5
34.47Buy
34.63Buy
MA10
33.79Buy
34.18Buy
MA20
33.72Buy
33.96Buy
MA50
33.97Buy
34.51Buy
MA100
36.59Sell
35.88Sell
MA200
38.53Sell
37.77Sell
GlaxoSmithKline’s (GSK) 10-Day exponential moving average is 34.18, while GlaxoSmithKline’s (GSK) share price is $35.1, making it a Buy.
GlaxoSmithKline’s (GSK) 100-Day exponential moving average is 35.88, while GlaxoSmithKline’s (GSK) share price is $35.1, making it a Sell.
GlaxoSmithKline’s (GSK) stock price is $35.1 and GlaxoSmithKline’s (GSK) 50-day simple moving average is 33.97, creating a Buy signal.
GlaxoSmithKline’s (GSK) stock price is $35.1 and GlaxoSmithKline’s (GSK) 100-day simple moving average is 36.59, creating a Sell signal.
GlaxoSmithKline’s (GSK) stock price is $35.1 and GlaxoSmithKline’s (GSK) 200-day simple moving average is 38.53, creating a Sell signal.

GlaxoSmithKline (GSK) Technical Indicators

Jan 30, 2025, 05:57 AM
Name
Value
Implied Action
RSI (14)
59.58
Neutral
STOCH (9,6)
94.23
Sell
STOCHRSI (14)
93.52
Sell
MACD (12,26)
0.11
Sell
ADX (14)
16.80
Buy
Williams %R
-12.53
Sell
CCI (14)
187.69
Sell
ATR (14)
0.63
-
Ultimate Oscillator
65.76
Neutral
ROC
3.36
Buy
GlaxoSmithKline’s (GSK) Relative Strength Index (RSI) is 59.58, creating a Neutral signal.
GlaxoSmithKline’s (GSK) Trend Strength Indicator (ADX) is 16.80, creating a Buy signal.
GlaxoSmithKline’s (GSK) Commodity Channel Index (CCI) is 187.69, creating a Sell signal.
GlaxoSmithKline’s (GSK) Price Rate of Change (ROC) is 3.36, creating a Buy signal.

FAQ

Is GSK a Buy, Hold, or Sell?
Based on GSK’s technical indicators, GSK is a Hold.
    What is GSK’s RSI (14)?
    GSK’s RSI (14) is 59.58, which suggests GSK is a Neutral.
      What is GSK’s MACD?
      GSK’s MACD is 0.11, which suggests GSK is a Sell.
        What is GSK’s 5-day moving average?
        GSK’s 5-day moving average is 34.47, which suggests GSK is a Buy.
          What is GSK’s 20-day moving average?
          GSK 20-day moving average is 33.72, which suggests GSK is a Buy.
            What is GSK’s 50-day moving average?
            GSK’s 50-day moving average is 33.97, which suggests GSK is a Buy.
              What is GSK’s 200-day moving average?
              GSK’s 200-day moving average is 38.53, which suggests GSK is a Sell.
                What is GSK’s Williams % R (14)?
                GSK’s Williams % R (14) is -12.53, which suggests GSK is a Sell.
                  What is GSK’s CCI (14)?
                  GSK’s CCI (14) is 187.69, which suggests GSK is a Sell.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis